Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients
Clinical trial NCT04718480 · COMPLETED
Trial details
- NCT number
- NCT04718480
- Sponsor
- SigmaDrugs Research Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-27
- Primary completion
- 2022-03-15
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.